All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.

Hepatitis B Virus

Hepatitis B
  • Aka, “Serum hepatitis.”
  • DNA Hepadnavirus, with an enveloped, icosahedral capsid.
  • Antigens
– Surface antigen = HBsAg (outnumbers HBV virions in serum) – Envelope antigen = HBeAg – Core antigens = HBcAg, HBeAg
  • Carried in the blood, tissue, and semen
– Transmitted via intravenous drug use, during birth, and is a sexually-transmitted infection. – Chronic carriers facilitates viral spread.
  • Clinical course varies depending on the host’s ability to clear the virus.
Acute infection with resolution. Adults are more often symptomatic, and have “serum sickness-like” problems due to the development of Hypersensitivity Type III reactions. For example, patients can experience rash, vasculitis, joint pain, and renal damage due to immune complex formation. – Chronic infection with liver destruction. Complications include cirrhosis, liver failure, and hepatocellular cancer. Hepatocellular cancer (HHC) is a significant cause of cancer-related mortality.
  • Establishment of chronic infection and long-term complications are more likely in neonates.
  • Extrahepatic problems (uncommon)
– Glomerulonephritis – Polyarthritis – Polyarteritis nodosa – Guillain-Barre
  • Histopathology:
– Chronic infection = "Ground glass" hepatocytes.
  • Serological values
HBV infection = HBsAg Acute = IgM & HBeAg Chronic = IgG. Higher infectivity HbeAg; Lower infectivity Anti-HBeAg – Replication/Infectious = HBeAg – Recovery = Anti-HBs; IgG – Immunized = Anti-HBs
  • Vaccine available
  • Post-exposure prophylaxis = Hepatitis B immune globulin.
  • Chronic infection treatment = antivirals, including entecavir, tenofovir, and others.
Hepatitis A Hepatitis C Hepatitis D Hepatitis E
References
Balogh, Julius, David Victor, Emad H Asham, Sherilyn Gordon Burroughs, Maha Boktour, Ashish Saharia, Xian Li, R Mark Ghobrial, and Howard P Monsour. “Hepatocellular Carcinoma: A Review.” Journal of Hepatocellular Carcinoma 3 (October 5, 2016): 41–53. https://doi.org/10.2147/JHC.S61146.
Gish, Robert G., Bruce D. Given, Ching-Lung Lai, Stephen A. Locarnini, Johnson Y.N. Lau, David L. Lewis, and Thomas Schluep. “Chronic Hepatitis B: Virology, Natural History, Current Management and a Glimpse at Future Opportunities.” Antiviral Research 121 (September 2015): 47–58. https://doi.org/10.1016/j.antiviral.2015.06.008.
Habib, Shahid, and Obaid S. Shaikh. “Hepatitis B Immune Globulin.” Drugs of Today (Barcelona, Spain: 1998) 43, no. 6 (June 2007): 379–94. https://doi.org/10.1358/dot.2007.43.6.1050792.
“Hepatic Pathology.” Accessed August 30, 2018. https://library.med.utah.edu/WebPath/LIVEHTML/LIVER036.html.
“Hepatitis B | NIDDK.” National Institute of Diabetes and Digestive and Kidney Diseases. Accessed September 6, 2018. https://www.niddk.nih.gov/health-information/liver-disease/viral-hepatitis/hepatitis-b.
“Hepatocellular Carcinomas.” National Institute of Environmental Health Sciences. Accessed September 7, 2018. https://www.niehs.nih.gov/research/resources/visual-guides/liverpath/hyperplast/hyperplast-2/hepatocellular_carcinomas/index.cfm.
Kappus, Matthew R., and Richard K. Sterling. “Extrahepatic Manifestations of Acute Hepatitis B Virus Infection.” Gastroenterology & Hepatology 9, no. 2 (February 2013): 123–26.
———. “Extrahepatic Manifestations of Acute Hepatitis B Virus Infection.” Gastroenterology & Hepatology 9, no. 2 (February 2013): 123–26.
Kasper, Dennis L., Stephen Hauser L., Larry Jameson J., Anthony S. Fauci, Dan Longo L., and Joseph Loscalzo. Harrison’s Principles of Internal Medicine. 19th ed. McGraw-Hill Education, 2015.
Levinson, W. Review of Medical Microbiology & Immunology. 14th ed. McGraw-Hill Education, 2016.
Papatheodoridis, George V., Henry Lik-Yuen Chan, Bettina E. Hansen, Harry L. A. Janssen, and Pietro Lampertico. “Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: Assessment and Modification with Current Antiviral Therapy.” Journal of Hepatology 62, no. 4 (April 1, 2015): 956–67. https://doi.org/10.1016/j.jhep.2015.01.002.
“Recommendation of the Immunization Practices Advisory Committee (ACIP) Postexposure Prophylaxis of Hepatitis B.” Accessed September 6, 2018. https://www.cdc.gov/mmwr/preview/mmwrhtml/00022736.htm.
“Viral Hepatitis B.” Accessed August 30, 2018. http://www.meddean.luc.edu/lumen/meded/orfpath/virhepb.htm.
“WHO | What Is Hepatitis?” WHO. Accessed August 29, 2018. http://www.who.int/features/qa/76/en/.
Images: “Ground Glass Hepatocyte.” Wikipedia, October 24, 2017. https://en.wikipedia.org/w/index.php?title=Ground_glass_hepatocyte&oldid=806833376.

Related Tutorials